ArticleCardiovascular diabetology2017

The use of lipid-lowering therapy and effects of antihyperglycaemic therapy on lipids in subjects with type 2 diabetes with or without cardiovascular disease: a pooled analysis of data from eleven randomized trials with insulin glargine 100 U/mL.

Markolf Hanefeld et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.